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Abstract
Background: Despite advances in testing and treatment, HIV incidence rates within European countries are at best stable or
else increasing. mHealth technology has been advocated to increase quality and cost-effectiveness of health services while dealing
with growing patient numbers. However, studies suggested that mHealth apps are rarely adopted and often considered to be of
low quality by users. Only a few studies (conducted in the United States) have involved people living with HIV (PLWH) in the
design of mHealth.
Objective: The goal of this study was to facilitate a co-design process among PLWH and clinicians across 5 clinical sites in the
European Union to inform the development of an mHealth platform to be integrated into clinical care pathways. We aimed to (1)
elicit experiences of living with HIV and of working in HIV care, (2) identify mHealth functionalities that are considered useful
for HIV care, and (3) identify potential benefits as well as concerns about mHealth.
Methods: Between January and June 2016, 14 co-design workshops and 22 semistructured interviews were conducted, involving
97 PLWH and 63 clinicians. Data were analyzed thematically and iteratively, drawing on grounded theory techniques.
Results: Findings were established into 3 thematic clusters: (1) approaching the mHealth platform, (2) imagining the mHealth
platform, and (3) anticipating the mHealth platform’s implications. Co-design participants approached the mHealth platform
with pre-existing concerns arising from their experiences of receiving or providing care. PLWH particularly addressed issues of
stigma and questioned how mHealth could enable them to manage their HIV. Clinicians problematized the compatibility of
mHealth with existing information technology systems and questioned which patients should be targeted by mHealth. Imagining
the potential of mHealth for HIV care, co-design participants suggested medical functionalities (accessing test results, managing
medicines and appointments, and digital communication channels), social functionalities (peer support network, international
travel, etc), and general features (security and privacy, credibility, language, etc). Co-design participants also anticipated potential
implications of mHealth for self-management and the provision of care.
Conclusions: Our approach to co-design enabled us to facilitate early engagement in the mHealth platform, enabling patient
and clinician feedback to become embedded in the development process at a preprototype phase. Although the technologies in
question were not yet present, understanding how users approach, imagine, and anticipate technology formed an important source
of knowledge and proved highly significant within the technology design and development process.
(JMIR Mhealth Uhealth 2018;6(10):e184)   doi:10.2196/mhealth.9856
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Introduction
Since the availability of effective antiretroviral therapy (ART)
by the end of the 1990s, HIV has transformed, in developed
countries at least, from a fatal to a chronic disease. People living
with HIV (PLWH) who have access to testing, treatment, and
care can enjoy a good quality of life and the same life
expectancy as the general population [1]. However, despite
several advances in HIV testing and new biomedical HIV
prevention modalities (such as early ART for prevention), the
incidence rates within European countries are at best stable, and
in some cases, they are even increasing [2]. In association with
longer life expectancy, this leads to a continuously increasing
number of people requiring long-term treatment and follow-up.
mHealth technologies, based on smartphone and Web 2.0 apps,
are seen by policy makers, developers, and some medical
professionals as an opportunity to increase the quality and
cost-effectiveness of health services while dealing with growing
numbers of patients [3-6]. Systematic reviews in the field of
HIV care have highlighted that mHealth interventions have
significant potential to support patients’ self-management and
treatment adherence [7,8]. Self-management is understood as
care that is led, owned, and undertaken by patients’ themselves.
To this end, mHealth tools can provide patients with ubiquitous
access to health data, information, and counseling beyond the
face-to-face clinical encounter, which might reduce the need
for routine clinical appointments and thus lower both the impact
of HIV on patients’ lives and health care expenditure. Effective
ART requires a 95% adherence to the antiretroviral medication
regime. In this respect, mHealth can be utilized to send
medication and appointment reminders to patients or provide
them with information about prescribed medicines and drug
interactions. A high level of treatment adherence contributes to
viral suppression and thus increases HIV patients’ life
expectancy and quality while decreasing the risk of forward
transmission of HIV [9].
Systematic reviews identify several smartphone apps for HIV
self-management and medication adherence available in app
stores [10-12]. However, the authors highlight that most of these
apps were infrequently downloaded and were considered of low
quality by users as they did not have desirable features. The
reviews stress the need for formative evaluations that include
end users within the design, development, and implementation
of mHealth devices to make them more accessible and
meaningful. In addition, studies on the general adoption of health
apps show that despite a vast range of available apps, only a
small number are actually used [13]. If the ambitions of mHealth
to improve quality and utilization of health care are to be
realized, co-design processes that bring together health care
providers, researchers, technology developers, and end users
are crucial to produce useful and usable mHealth technologies.
Only a few studies have involved PLWH to inform the design
of smartphone apps for HIV prevention, treatment, and care
[14-16] or to test prototypes [17]. Furthermore, in the context
of HIV care, clinicians are almost never considered as potential
adopters of mHealth technology and so are rarely included in
co-design initiatives. So far, only 1 study has assessed HIV
clinicians’ attitudes toward mHealth and, thereby, outlined
perspectives of how this technology could be integrated into
clinical care pathways [18]. Moreover, the involvement of
users—most often PLWH—tends to be restricted to the initial
mHealth design phase, and only very recently are studies
beginning to extend user involvement (focusing on young men
who have sex with men) to the implementation phase of mHealth
interventions [17,19]. Although critical decisions about what
desired functionalities are included in the final product can be
made in the design phase, it is only later in the implementation
phase that actual experiences with mHealth devices can be
captured and reflected upon. Finally, most participatory studies
were conducted in the United States [14-19], and to our
knowledge, there is no evidence of how PLWH and clinicians
in European health care systems evaluate the potentials and
risks of mHealth for use in HIV treatment and care.
In this paper, we address these gaps by presenting results from
the first phase of an mHealth co-design process involving 97
PLWH and 63 clinicians from 5 clinical sites in the European
Union (EU). We asked co-design participants to reflect, in the
design phase, on the potentiality and risks they associated with
mHealth in the context of HIV treatment and care and on the
precise functionalities that they thought could support
self-management of HIV. These findings were used to inform
the development of a comprehensive mHealth platform that is
currently being implemented within clinical treatment pathways
in the 5 clinical sites. Later phases of the co-design work will
seek to capture patients’ and clinicians’ experiences in the use
of the platform to support continuous improvement as new
pathways and technologies become embedded into HIV care.
Methods
The Evaluating mHealth Technology in HIV to
Improve Empowerment and Health Care Utilization:
Research and Innovation to Generate Evidence for
Personalized Care Project
The co-design process presented in this paper is part of the
Evaluating mHealth Technology in HIV to Improve
Empowerment and Health Care Utilization: Research and
Innovation to Generate Evidence for Personalized Care
(EmERGE) project (please refer to [20]), which is funded under
the EU’s Horizon 2020 Programme (project period: 2015-2020).
The project aims to develop, implement, and evaluate an
mHealth platform to support self-management among HIV
patients in 5 clinical sites (Brighton, Antwerp, Zagreb,
Barcelona, and Lisbon). The platform is currently being
integrated into clinical HIV pathways and provides users (PLWH
and clinicians) with smartphone and Web apps to facilitate
access to personal health data and improve patient-provider
communication. Through these functionalities, the EmERGE
mHealth platform aims to reduce some routine clinic visits of
HIV patients and support patients to better self-manage their
own care. According to international guidelines, PLWH are
currently seen every 3 to 6 months [21]. However, the EmERGE
mHeaIth care pathway requires HIV patients to see their
consultant face-to-face only every 12 months, while they can
continuously monitor their blood results and maintain contact
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with their clinic through the smartphone app. Previous studies
that have investigated the potential of mHealth in HIV care have
suggested that such reductions in hospital visits are desirable
for increasing the quality of life of PLWH [18]. The EmERGE
project, as a whole, aims to validate the acceptability, usability,
and effectiveness of the mHealth platform; assess its impact on
patient self‐management and empowerment; analyze its
cost-effectiveness; and disseminate the mHealth platform across
various European health care settings as a sustainable, effective,
safe, and economic modality for HIV care. The co-design
process, outlined in this paper, constitutes an essential part of
the sociotechnical evaluation work package, which seeks to
identify and support factors that can help facilitate the successful
introduction of the new care pathway. In the first year of the
project (June 2015 to June 2016), in the platform’s initial design
phase, we undertook a co-design process among potential users
of the EmERGE platform—PLWH and clinicians. The results
from this process are presented in this paper and have informed
the technology development. Further research is currently being
carried out, as the platform is implemented, to investigate how
it reconfigures practices of HIV care [22]. Study approval was
obtained from the ethics committee of the University of
Brighton, the National Health Service (NHS) Health Research
Authority, and governance boards at each clinical site.
Facilitating Co-Design
Co-design research is recognized as an important means to
establish the effective and responsible delivery of mHealth
technologies [23-25]. In this section, we highlight how we
engaged PLWH and clinicians in co-design to elicit current
challenges of HIV care and to consider the potential uses and
implications of integrating an mHealth platform within existing
care pathways.
To initiate co-design, we worked closely with HIV clinicians
and patient organizations, in particular, the European Aids
Treatment Group (EATG) and its local partners within each
study site. Collaboratively, we designed a protocol for engaging
PLWH and clinicians alongside the iterative phases of the
platform’s design and implementation. We decided to use
co-design workshops as the main method through which
potential users in design activities to develop ideas and identify
challenges could be involved [26]. However, co-design
workshops are also recognized as a challenging method.
Time-constrained clinicians as well as some of the more
vulnerable and often stigmatized HIV patients can find it
difficult to participate in lengthy, group-based workshops. To
attend to this potential shortcoming, individual interviews were
offered as an alternative means to engage participants who were
unwilling or unable to attend workshops.
With our clinical and PLWH-community partners, we
established a schedule for workshops and interviews. First, the
idea of using an mHealth platform for HIV care was presented
as a narrative stimulus to identify ideas and new ways of doing
HIV care. Thereafter, co-design activities were conducted in 3
phases that all drew on the use situation as a fundamental
starting point for design [27]. First, participants were encouraged
to discuss current practices of HIV care and uses of apps and
mHealth technologies in their everyday lives. Second, they were
prompted to imagine potential functionalities and features that
could be provided through mHealth platforms and used within
HIV care. Finally, participants were encouraged to anticipate
potential implications of the use of mHealth platforms. Together,
these open areas of questioning facilitated a range of views and
experiences, including apparently contradictory ones.
PLWH-community partners at each of the study sites were
trained as peer researchers to mobilize interest in the study,
support the recruitment of patients, and facilitate co-design
workshops and interviews in the local languages in cases where
participants were not fluent in English. Community partners
were regarded as trustworthy and knowledgeable by most
PLWH, and they were experienced in moderating groups and
working with vulnerable people.
Recruitment and Data Collection
We attempted purposive sampling to recruit a diversity of
PLWH (eg, gender, age, and nationality) and clinicians (eg,
having a good representation of doctors and nurses) while
accepting that fieldwork pragmatics (such as study timelines,
access to potential participants, etc) will limit its success. A
total of 97 PLWH and 63 clinicians were recruited into the
co-design process. From the 97 PLWH we recruited, 19 were
women. Moreover, 65 PLWH identified themselves as gay or
lesbian, 26 as heterosexual, 3 as bisexual, and 3 belonging to
none of these categories. The age range was 23 to 78 years with
11 participants under 30 years, 75 between 30 and 59 years, and
7 were 60 years or above (4 missing values). The length of
diagnosis of HIV ranged from 0.5 to 31 years. Furthermore, 64
of the PLWH were working or studying, 21 were unemployed,
and 12 were retired. PLWH had 14 different nationalities and
13 identified themselves as belonging to a migrant community.
From the group of 63 clinicians, 19 were male. Clinicians
included 40 doctors, 10 nurses, 4 psychologists, 4 pharmacists,
2 social workers, 2 nutritionists, and 1 sexologist.
A total of 14 workshops and 22 interviews were conducted at
the offices of community partners, at hotels, or in the clinic,
depending on what was appropriate. Table 1 shows the
distribution of data collection and participants across the 5 study
sites. The small number of clinicians (n=4) who participated in
Zagreb is due to the size of the HIV clinic there (just 8 clinicians
and a total of 862 patients). The other sites have between 2246
and 4846 patients and employ between 26 and 30 clinicians
(according to 2014 data). In workshops indicated as mixed,
PLWH and clinicians were involved in discussions together.
While workshops with clinicians and mixed ones were conducted
in English by the academic researcher, workshops with PLWH
were facilitated in the local language by a community partner,
with the academic researcher and a member of the EATG also
present. An instant translator enabled the researchers to take
notes and raise additional questions, as appropriate. Moreover,
15 interviews were conducted in English by the academic
researcher and 7 interviews with PLWH by community partners
in local languages. Throughout the data collection, the EATG
member and the lead author exchanged and discussed their notes
and debriefed impressions of the workshops with community
partners. Workshops and interviews were audio recorded
(average recording length: 95 min and 45 min, respectively).
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All recordings were transcribed verbatim and non-English
transcripts were thoroughly translated. Participants provided
written informed consent before the interview or workshop, and
PLWH received €25 or £20 remuneration for participation.
Analytic Approach
Data were analyzed thematically and iteratively, drawing on
grounded theory techniques [28]. First, transcripts were carefully
read-through by the first author of this paper (BM), and initial
thoughts were documented. Open coding, conducted by BM,
involved a sequential analysis where sentences with significant
meaning were assigned first conceptual labels. These initial
codes were then discussed among the whole academic research
team (BM, FH, and MD) on a bimonthly basis, whereby they
were continuously revised and established into thematic clusters
and categories. Furthermore, preliminary findings were
continuously discussed with the EATG, PLWH-community
partners, and the whole EmERGE Consortium. NVivo 11
software (QSR International Pty Ltd) was used to support the
management of the textual data and to organize the codes being
assigned to the transcripts.
Table 1. Data collection across study sites.
Participants’ characteristicsStudy site and mode of data collection
Total participantsFemaleMale
CliniciansPLWHCliniciansPLWHCliniciansPLWHa
Brighton (Br)
—8—1—71 workshop PLWH
—9—3—61 workshop PLWH
—2—1—12 interviews PLWH
11—8—3—1 workshop clinicians
1—1———1 interview clinicians
Lisbon (Li)
—8—4—41 workshop PLWH
—10—3—71 workshop PLWH
—4———44 interviews PLWH
13—11—2—1 workshop clinicians
1———1—1 interview clinicians
Antwerp (An)
—10—1—91 workshop PLWH
3621151 workshop (mixed)
—3———33 interviews PLWH
13—9—4—1 workshop Clinicians
Zagreb (Za)
—7—2—51 workshop PLWH
432—231 workshop (mixed)
—5—1—45 interviews PLWH
Barcelona (Ba)
—10—1—91 workshop PLWH
5641151 workshop (mixed)
—6———66 interviews PLWH
12—7—5—1 workshop clinicians
639744191978Total (7 workshops PLWH; 3 workshops [mixed]; 20 interviews PLWH;
4 workshops clinicians; and 2 interviews clinicians)
aPLWH: people living with HIV.
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Design Specification and Priorities
A further step in co-design involved ensuring that the outcomes
of workshops and interviews were embedded in decision
making. Therefore, the outcomes of our study were presented
and discussed at EmERGE Consortium meetings, where lead
clinicians from each study site, PLWH (represented through
EATG), researchers (from University of Brighton), and
technology developers were represented and had the opportunity
to provide feedback. Following these initial discussions, a
technical co-design group, consisting of 2 representatives from
these parties (clinicians, PLWH, researchers, and developers),
was formed to outline a design specification document and
discuss priorities for the development of functionalities and
features to be included in the prototype platform. This group
held several meetings and worked in partnership with
community partners, clinicians, and the project consortium on
an ongoing basis to ensure that priorities were reviewed and
rearticulated in light of ongoing changes and specific contexts.
In the following section, we present the results from co-design
workshops and interviews. Thereby, we use quotes from
participants, only indicating participant (P=PLWH; C=clinician),
study site (by first 2 letters), and mode of data collection
(WSm=workshop mixed, I=interview), for example,
P_Za_WSm. In the discussion section of the paper, we will
outline how these results informed the development of the
EmERGE prototype platform.
Results
Overview
As Textbox 1 illustrates, we established our findings into 3
broad thematic clusters: (1) approaching the mHealth platform,
(2) imagining the mHealth platform, and (3) anticipating the
mHealth platform’s implications. At the start of the co-design
workshops and interviews, we introduced the aim of the
co-design study, namely, to explore the concept of an mHealth
platform to participants. One specific aim of our study was to
elicit experiences of living with HIV or working in HIV care.
Therefore, before discussing the possible functionalities that
could be included within such a platform, we asked participants
to broadly reflect on their experiences of living with HIV or of
working as an HIV clinician. Throughout the data analysis, it
became evident that these general experiences formed the ways
in which PLWH and clinicians were reflecting upon possible
functionalities, opportunities, and drawbacks of an mHealth
platform. To indicate this, we labeled initial themes as questions
by which PLWH and clinicians were approaching the mHealth
platform. From the backdrop of these approaches, our
participants started imagining the mHealth platform and
articulated tentative interpretations about what an mHealth
platform for HIV care could do. Thereby, linked to our second
study aim, potential functionalities and components of the
platform were discussed. Once potential functionalities were
conceptualized, study participants then elaborated connections
between technology functions and the wider context within
which it will be utilized. Thereby, participants anticipated the
platform’s potential implications for self-management and the
provision of health care and, thus, contributed to our third study
aim to understand the potential benefits of, and concerns about,
mHealth.
Approaching the mHealth Platform
Both PLWH and clinicians approached discussions about the
proposed mHealth platform with pre-existing concerns arising
from their experiences of receiving or providing HIV care.
While broadly reflecting on experiences of living with HIV,
PLWH particularly addressed the issue of stigma and the ways
in which they attempt to take control of HIV. Clinicians working
in the field of HIV care focused on their experiences with digital
technologies and questioned what type of patient will be capable
of engaging with mHealth.
Patients’ Approaches
Renegotiating Stigma?
Experiences of stigma were a topic within most of the workshops
and interviews. Several PLWH argued that the general public
as well as some health care professionals still lack knowledge
about HIV. To illustrate this impression, 1 participant reported
an incident where his neighbor, while inviting him for coffee,
told him: “...but bring your own mug” (P_Za_WS). Other
participants referred to situations where they have been
suspended from work when their employer found out that they
were HIV positive. Due to such experiences, many participants
stated that they do not disclose their HIV status to friends or
even their families and thus often feel isolated as they “don’t
have someone to talk about [HIV]” (P_Za_WSm, male).
Moreover, when engaging with health care professionals, some
PLWH are reluctant to disclose their HIV status:
So even when you go for medical check-ups, you keep
quiet...you don’t want to be put in that situation where
you’re labelled, and where you wouldn’t get the best
possible medical care just because you are HIV
positive. [P_Za_I, male]
Due to such experiences, PLWH approached the mHealth
platform by questioning how it would renegotiate stigma.
Thereby, the platform’s functionalities and features were
discussed against the backdrop of protecting or jeopardizing
confidential HIV data (see section Security and Privacy), and
suggestions were made to use the platform to inform the broader
public to reduce the stigma of HIV (see the section Changing
Public Attitudes Toward HIV).
New Opportunities for Control?
The heterogeneous practices of keeping in control of one’s
condition were an integral part of patients’ illness narratives.
Thereby, the adherence to the antiretroviral medication regime
was a pressing element: “I know if I don’t take the pills I die”
(P_Br_WS, male). Most PLWH argued that they use alarms to
remember taking their medicines: “with my mobile phone, I set
the time...to take medication. For otherwise I forget” (P_An_I,
male). Some PLWH, however, stated that they manage their
medication intake by integrating it within their “natural
schedule” (P_Li_I, male) of everyday routines and thus do not
rely on additional reminders.
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Textbox 1. Thematic clusters and categories.
• Approaching the mHealth platform (experiences)
• Patients’ approaches: Renegotiating stigma? New opportunities for control?
• Clinicians’ approaches: Compatibility and added value? Who constitutes the target group?
• Imagining the mHealth platform (functionalities)
• Medical functionalities: accessing test results; managing medicines; managing appointments; and digital communication channels
• Social functionalities: peer support network; international travel; and changing public attitudes toward HIV
• General features: security and privacy; credibility; language; sensitivity for disabilities; costs; training and tutorials; and other technicalities
• Anticipating the mHealth platform’s implications (benefits and concerns)
• Implications for self-management: Creating (un)certainty? Reconfiguring relationships? Altering the understanding of health?
• Implications for health care provision: Replacing traditional care pathways? Rationalities of mHealth? Effects on workload?
Dealing with situations of uncertainty was another important
aspect of managing HIV. Such situations can occur when pain
or certain symptoms are experienced by PLWH, but they are
unsure if these are side effects of HIV medication or part of the
normal process of “getting older” (P_Li_WS, female). To deal
with such situations, PLWH have to seek for information and
advice. Although the HIV consultant was seen as the most
trusted source of health information, several PLWH argued that
general practitioners (GPs) are often not capable of providing
adequate advice as they often lack basic knowledge about HIV
and thus are inclined to relate every medical problem to HIV:
“you go to the GP, he will tell you ‘It’s HIV’” (P_Br_WS,
female). Community groups were perceived as another important
source of health information. For specific health-related
problems (eg, side effects of medication), PLWH valued
expertise based on experiences from someone who has lived
through it. With these concerns in mind, PLWH approached
the mHealth platform by questioning how it could create new
opportunities for control. For example, they asked whether the
platform could be seen as a device to keep on top of one’s
treatment adherence (see the section Managing Medicines and
Managing Appointments) and if it could offer new ways to get
in touch with health care providers (see the section Digital
Communication Channels) or community groups (see the section
Peer Support Network).
Clinicians’ Approaches
Compatibility and Added Value?
Clinicians often discussed their hospital’s technological systems
and reflected on whether the mHealth platform would be
compatible and provides added value. Some clinicians expressed
a general impression that the health care sector is slow in
adopting new technologies, saying, “...in the NHS we fall way
behind the rest of the world in terms of using social media and
electronics in managing our patients” (C_Br_WS, male doctor).
This was seen as problematic because by considering
technological advances, the limits of old technological systems
became apparent. In this way, a clinician in Zagreb illustrated
the limits of discussing blood test results through telephone
lines:
...we ask people [patients living remote from the
clinic] to call in approximately two to three weeks
after they have been to the visit [where blood was
drawn] so that we can discuss the new lab result and
I don’t think that the system is working perfectly
because we cannot answer the phone every time…it
happens that the patient doesn't know his lab result
until his next appointment. [C_Za_WSm, male doctor]
In similar ways, the limits of existing email communication
with patients (Brighton) with respect to data security were
addressed or an existing telecommunication platform for virtual
video consultations (Barcelona) was criticized for being only
accessible through a conventional Web interface (and not
through a smartphone app). Established technological systems,
however, were also valued because they have already been
adopted within work practices. Therefore, some clinicians
questioned if the proposed mHealth platform could be integrated
into established systems:
I think that [the mHealth platform] is useful if we
have one instrument...if it’s just one more instrument
it’s not worth it ’cos it’s time-consuming, so I think
it it’s important to be a platform that connects with
the existing ones. [C_Li_WS, female clinician]
From the backdrop of their work routines and experiences with
established technological systems, clinicians approach the
mHealth platform by questioning its added value and
compatibility. In this regard, clinicians asked how the integration
of the platform would affect their workloads (see the section
Effects on Workload).
Who Constitutes the Target Group?
Clinicians also addressed the diversity of the patient population.
Several clinicians emphasized how important it is “to identify
very carefully what kind of patient can improve with this
[platform]” (C_Ba_WS, male doctor). In terms of patients’
health conditions, most clinicians argued that only patients that
“have been doing well for many years” (C_Li_WS, female
doctor) and are medically “stable” (C_An_WS, female clinician)
should be considered as target group for the mHealth platform.
Stable HIV patients have controlled viral loads and cluster of
differentiation 4 (CD4) counts, and this was seen as essential
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in relation to the platform’s functionality accessing blood results
(see below). It was outlined that, for stable patients, the blood
test is rather a routine checkup, and thus, the results are hardly
surprising because they are mostly within a certain range. These
patients, therefore, would—presumably—not become unsettled
when retrieving lab results on a smartphone app. In the case of
nonstable patients, however, results are fluctuating, and several
clinicians emphasized that such patients would not be able to
interpret and make sense of these fluctuations outside of a
face-to-face consultation. In a clinical consultation, the meaning
of the result can be assessed and implications for the treatment
negotiated from the backdrop of patients’ broader psychosocial
health issues. Hence, it was argued that nonstable patients should
not have access to their results before a clinical consultation.
Furthermore, it was emphasized that patients require “a certain
skill set” (C_Br_I, female nurse) to use the smartphone app
(provided with the mHealth platform) and to interpret data and
information that are made available on it. Therefore, most
clinicians considered only “highly educated” (C_Li_WS, female
clinician) and “experienced” (not newly diagnosed) patients
(C_Ba_WS, female clinician) as potential target group for the
mHealth platform (see the section Creating (Un)certainty?).
These approaches had a significant impact on how clinicians
discussed potential functionalities and implications of mHealth.
This will be outlined in the following section.
Imagining the mHealth Platform
From the backdrop of the experiences of receiving or providing
care, participants imagined and articulated potential
functionalities and features that could be provided through
mHealth. Although clinicians largely suggested functions that
we conceptualized as medical functionalities, PLWH,
additionally, considered social functionalities and general
features in more depth.
Medical Functionalities
Accessing Test Results
Co-design participants discussed whether the mHealth platform,
or rather the app provided for use by patients through this
platform, could provide access to blood test results:
If I could receive...the results of my blood tests
through the app, I wouldn’t have to go to the
internist...the app could save me a whole lot of health
expenses. [P_An_WS, male]
In line with this statement, several PLWH and clinicians argued
that for some patients (see the section Who Constitutes The
Target Group?), regular appointments are just an exertive routine
to collect blood results. By having remote access to results, it
was argued that some routine visits to the clinic could be
avoided, and this would contribute to patients’ quality of life
(by saving traveling and waiting time and/or avoiding the
potential disclosure of the HIV status by encountering people
in the clinics’ waiting rooms). Furthermore, it was emphasized
that by having access to medical data, patients can become more
knowledgeable about their condition (see the section Altering
the Understanding of Health?) and could share data with health
professionals to agree on treatment decisions: “the analysis
could be showed to other doctors” (P_Li_WS, male). However,
questions were raised about how patients could best be enabled
to interpret results. Most clinicians suggested that only “a
selected part of the blood analysis” (C_Ba_WS, male doctor)
should be sent to the patient. There was a certain consensus
among clinicians that, rather than sending the whole analysis,
results should be restricted to viral load, CD4 count, cholesterol
levels, and kidney and liver function. Furthermore, it was
emphasized that results could be accompanied with a “small
message” (C_An_WS, female clinician) from the doctor or a
“sort of colour coding” (P_Br_WS, male) that helps to interpret
the results.
Managing Medicines
As described above, patients approached the mHealth platform
with concerns about maintaining control over their health. The
adherence to the medication regime, in particular, was perceived
as a considerable stress factor among several PLWH. These
concerns were reflected in how they imagined the platform and
its functionalities. PLWH and clinicians mentioned that a tool
to assist the management of medicines would be an important
function in the app. In particular, such a function would include
reminders to take medicines. Although several PLWH stated
that they already set reminders on their smartphones, it was
argued that an app, provided by the mHealth platform, could
offer a more comprehensive reminder system. In this regard,
PLWH referred to complex social situations where they were
not immediately able to take their medication when the alarm
on the smartphone goes off and thus were unsure at a later point
whether they had actually taken their medication. Therefore,
PLWH discussed the possibility of a “snooze” button
(P_Br_WS) and additional reminders that “will just keep
reminding you until you do it [take the medicine]” (P_Za_I).
Another problem was drug interactions, as 1 participant pointed
out:
[Doctors] give me medication that interfered with my
retroviral drugs...there should be something that we
ourselves could manage this situation...An application
where we could see if we can take the drugs A, B or
C with this cocktail of antiretroviral drugs.
[P_Li_WS, female]
In line with this quotation, several PLWH stressed that health
care professionals (aside from the HIV consultant) often lack
knowledge about the interactions of the medicines. Therefore,
an option to recheck interactions within an mHealth platform
was seen as essential.
Managing Appointments
Some PLWH reported that they quite often miss appointments
for their medical check-ups:
I have missed a lot of appointments. I think it would
be useful to have some reminders to tell me.
[P_Li_WS, female]
Accordingly, both PLWH and clinicians regarded reminders as
an important tool to ensure “that people come to their
appointments” (C_An_WS, female clinician). Moreover, the
booking of appointments was experienced as stressful by some
PLWH, who said, “...many times I’ve had to change my
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appointments, and I’m ringing up and I can’t get through.”
(P_Br_WS, female).
Both arranging appointments through the telephone and at the
reception desk were experienced as time consuming. Therefore,
PLWH stated that the mHealth platform could offer “an online
calendar, if there is an empty spot that suits you...you click on
it” (P_Ba_WS, male).
Digital Communication Channels
Participants explored the different ways in which the mHealth
platform might offer communication channels between PLWH
and health care providers. One option, particularly emphasized
by clinicians, was indicated as “push notifications” (C_Br_WS,
female clinician). This was seen as a way for clinicians to inform
specific patients about new trials, medical innovations, or ways
to maintain a healthy lifestyle. Some PLWH emphasized that
they would appreciate a “newsfeed” (P_Ba_WS, male) that
notifies “if something new comes out in the world of HIV
inventions” (P_An_WS, female) or provides information about
“diets, sports, sex, whatever!” (P_Ba_WSm, male). However,
several PLWH proposed a “direct messaging service”
(P_Ba_WS, male) where messages could be exchanged in both
ways—between patients and clinicians; this would help in
situations of uncertainty where medical advice is required.
Among clinicians, however, two-way communication messaging
was seen as more controversial. Although some clinicians
regarded it as essential that patients could contact their clinician
in case of problems or questions, others had “misgivings about
having a two-way communication...because we’re fighting the
wolf...volumes of free text” (C_Br_WS, male doctor). The
quotation illustrates that some clinicians feared that a two-way
messaging system would produce an unmanageable workload
(see the section Effects on Workload?). Another option for
communication that participants discussed was virtual
consultations. Although video consultations seem to most
appropriately simulate the face-to-face consultation, they are
still embedded within potentially constraining spatiotemporal
contexts. As 1 participant puts it:
I probably wouldn’t use video calling, because...you
have to schedule in a time, make sure you’re in a
specific place that can be completely private to have
that conversation. [P_Br_I, male]
Social Functionalities
Peer Support Network
While reflecting upon functionalities of the mHealth platform,
the distinction between medical and social aspects was
emphasized by PLWH:
I do see a difference between the medical world and
the rest of the world...nearly all information comes
from doctors...there is no community
anymore...managing, eh, your infection is also about
sharing your experience. [P_An_WSm, male]
To complement medical knowledge with experiential expertise,
some PLWH argued that the platform should facilitate a peer
support network through a chat function. Besides the exchange
of experiences, a chat forum was also seen as an opportunity
for PLWH to overcome isolation. In this way, 1 participant
argued that:
[T]hey [clinicians] are not here at midnight...when
you are scared and wake up in tears and shaking:
“What do I do, oh my God, I’m HIV positive.” So I
think that it will be a very good thing that you can go
on the app and see someone online and only talk
about HIV or about the weather... [P_Za_WSm, male]
International Travel
PLWH mentioned international travel as another aspect of social
life that could be supported by the new mHealth platform. It
was suggested that it could provide general information about
the implications of traveling with HIV, such as travel restrictions
to certain countries, information about travel documents (eg,
certificates for the antiretroviral medication), and advice for
situations of emergency (eg, losing the medications).
Furthermore, PLWH discussed whether an mHealth platform
could help to manage medicines between different time zones,
saying, “...it’s important to address the issue of schedules of
intakes of the medicines when traveling and changing time
zones” (P_Li_I, male).
Changing Public Attitudes Toward HIV
In regard to the target group of the mHealth platform, some
PLWH stated that it should not only be for “us [PLWH], but
for everyone” (P_Ba_WS, male), as by providing information
on HIV to the general population, the platform could “take away
a bit of the discriminatory burden of this disease” (P_Li_WS,
male).
General Features
Security and Privacy
As a general feature, the mHealth platform (and its related app)
needs to provide “some other standard of security” (C_Ba_WS,
male doctor). This quotation illustrates the perspective of most
study participants (PLWH and clinicians) who emphasized that
because of the high stigma around HIV, the platform should
accomplish the highest level of security and privacy. In this
way, participants argued that the app design should be
discrete—“it should not have 1000 red ribbons” (P_An_WSm,
male)—and posed questions such as how the medical records
would be encrypted, how the data would be stored, and by whom
it would be managed or shared. Although there were several
questions with regard to security and privacy, most PLWH
stated that they already use apps for banking and other purposes
and thus would trust an mHealth platform if it accomplishes a
similar level of security. Some other participants, however,
rejected the idea of having their confidential HIV data processed
through an mHealth platform:
Even though it has codes and all kind of stuff…this
app is online…Anybody can hack my email…I don’t
want it to maybe one day, come out…if you say, “This
app is here you can download it,”I will say:“No,
thank you.” [P_Za_I]
In discussing these security concerns with the EATG and our
community partners, it was elaborated that there is a central
distinction between banking apps and HIV health apps. The
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point was made that there is a general expectation that banks
will return any money lost to you through security failure on
their part. Money can be paid back, but the disclosure of
sensitive health information cannot be undisclosed and may
have a significant impact on people’s lives.
Credibility
Credibility was another topic that emerged in our data. PLWH
often stated that it is important that the mHealth platform and
its related app come from a trusted institutional body. PLWH
pointed out that, for them, health care providers and patient
organization have more credibility than pharmaceutical
companies.
Language
The language used by the mHealth platform was another
discussion point among PLWH who underlined that it should
be available in their local language and the language should not
be “over-complicated” (P_Br_WS, male).
Sensitivity for Disabilities
Sensitivity for disabilities was an issue mentioned by some
participants. In particular, an option for voice recognition and
a text narrator built within the mHealth platform was considered
as important to make the app accessible for users with less
eyesight, dyslexia, or for people who are analphabetic.
Costs
The app provided by the mHealth platform, according to most
PLWH, should be free of cost. However, some PLWH expressed
willingness to pay for a good-quality app, saying, “...it would
not necessarily have to be completely free of charge, because
you don’t get something for nothing, but maybe the basic version
could be free” (P_An_WS, male).
Training and Tutorials
The importance of some kind of training to use the mHealth
platform and its app was stressed by both clinicians and PLWH.
It was argued that PLWH could be introduced to the app by
health care professionals, within specific training workshops or
through tutorials that are included within the app.
Other Technicalities
PLWH addressed a range of other technicalities that they
perceived as relevant for an app. Thereby, the app’s battery and
memory consumption within the smartphone as well as its speed
were questioned. An offline access to the information within
the app was considered useful. Moreover, it was suggested that
an option to individualize the app would be important. Options
to individualize the app were seen in selecting the functionalities
one wants to see on the app’s dashboard, choosing one’s own
app icon, or selecting different types of reminders (eg, for
medication intake).
Anticipating the mHealth Platform’s Implications
Co-design participants also discussed the potential implications
of an mHealth platform for self-management and for the
provision of health care. These implications were debated quite
controversially, emphasizing both benefits and risks. To indicate
these controversies, we labeled the following themes as
questions.
Implication for Self-Management
Creating (Un)certainty?
Both PLWH and clinicians debated whether an mHealth
platform would contribute toward certainty or uncertainty within
the self-management of HIV. Some participants were convinced
that receiving results through an mHealth platform would create
more certainty and reassurance. In this way, 1 participant
explicated:
To access something, that seems quite interesting,
you know, and perhaps just to check the percentage
of your CD4 and your viral loads...that’s all about
reassuring and taking care of your health condition,
even just doing those quick checks. But you’re in
control of it. [P_Br_I, female]
In addition, some clinicians were convinced that experienced
patients would be able to interpret blood test results,
acknowledging that “patients have learnt quite quickly to speak
the language of HIV bloods” (C_Br_I, female nurse). It was
argued that through an mHealth platform, PLWH could become
more informed and reassured. These positive perspectives
toward the platform were rejected by other participants who
pointed out that having instant access to medical results outside
of a face-to-face clinical encounter could create anxiety and
uncertainty among PLWH.
...anxiety about your results, because you don’t know
how to interpret them, you may have a blip on your
viral load and that means nothing, but if you have
access you may be anxious for a couple of days before
going to the doctor, and she explains to you that’s
nothing. [P_Li_I, male]
From the perspective of these participants, medical results are
best discussed within a face-to-face clinical encounter. Thereby,
assistive measures that could help to interpret the results
accessible through the platform (eg, color coding, see the section
Accessing Test Results) are not seen as sufficient to inform
health decisions. Such decisions, according to these participants,
are best embedded in the physical clinical encounter where
individual feelings and illness experiences can be expressed
and treatment decisions can become the product of a deliberative
process of care, balancing experiential and medical knowledge.
Reconfiguring Relationships?
Another discussion emerged around the question of how
mHealth would affect the relationship between patients and
clinicians. Most PLWH mentioned that they have built a strong
relationship with their HIV consultant and were “loyal” (P_Li_I,
male) to them over a long period. In this regard, some were
worried that, if communication would move from the physical
encounter toward mHealth, “the relationship [with the
consultant] is not the same” (P_Ba_I, male). Furthermore,
clinicians emphasized that it is crucial to first establish a
relationship with patients in face-to-face interactions but
emphasized that this could then be moved to digital
communication. In this way, a female doctor suggested to
PLWH in a mixed workshop:
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once...we already have a previous relationship, we
already know each other...I want to propose to you
to stop seeing you in face-to-face visits. [C_Ba_WSm]
Some PLWH stressed the potential of the mHealth platform and
the related app to create a closer relationship with clinicians,
suggesting “an app that you can use to be in touch with your
own doctors” (P_An_I, male). To do this, as was acknowledged,
the platform would need to provide two-way communication
(see the section Digital Communication Channels).
Altering the Understanding of Health?
Another point discussed among PLWH was how far the mHealth
platform could contribute toward a more pronounced
understanding of one’s HIV condition. Most PLWH saw data
as essential to gain knowledge about one’s condition. In this
way, the potential of the platform to store the medical history
and visualize it on images or graphs was outlined. This was
valued for enabling an in-depth understanding of the body and
new options to monitor and control HIV:
Regarding the history, it’s always important. I think
that it’s through there that we can reach conclusions
about what is doing us better, doing us worst and
maybe one day to see a marker and realize “Look,
after all THIS is what degraded THIS.” [P_Li_WS,
female]
...it might be nice to have something that’s sort of
telling you, you know, where you are on the scale.
[P_Br_WS, male]
Other PLWH, however, argued that to become knowledgeable
about their health, they privilege their own (bodily) experience,
feelings, and self-awareness:
I know myself and I know when I don’t feel
good...Sometimes it’s better to ignore some things
like that [medical data]. I mean you are living with
the disease, but you don’t want to think about it every
day. [P_Za_I, female]
These participants emphasized that through an mHealth platform
that pushes health data and alerts, they would be constantly
confronted with their disease. Technology was thus perceived
as invasive, disrupting practices of everyday life, and exposing
PLWH to the risk of becoming “obsessed” (P_Ba_I, male) with
their condition.
Implications for Health Care Provision
Replacing Traditional Care Pathways?
Participants questioned whether an mHealth platform would
replace or complement routine face-to-face consultations within
the traditional pathway of HIV care. In this respect, both
clinicians and PLWH agreed that some face-to-face clinical
encounters are essential for effective HIV care. As the following
quote illustrates, some participants argued that social aspects
such as sexual practices, relationships, and family problems
could not be appropriately discussed through digital
communication channels:
I don’t see myself sitting behind a computer and
having a discussion about relationships...for me that's
a drawback. [C_An_WS, male doctor]
Furthermore, it was stressed that only a personal relationship
with the patient would facilitate a good consultation around
social issues. Some clinicians also emphasized that:
We do a physical exam and patients sometimes are
not aware of...physical appearance or the presence
of symptoms. [C_Li_WS, female clinician]
An appropriate physical examination, it was argued, could not
occur outside the face-to-face encounter. By pointing to such
restrictions, both clinicians and PLWH emphasized that an
mHealth platform should complement, rather than substitute,
face-to-face visits:
I don’t think that this kind of...application should be
a substitute of the medical visit...But, they can work
together. [P_Li_I, male]
Rationalities of mHealth?
Other concerns were related to the rationalities behind the
utilization of an mHealth platform. In particular, it was
questioned whether such a platform would be utilized to improve
the quality of care or to downsize health care expenditure. Some
clinicians pointed out that an mHealth platform would probably
save resources but, at the same time, could contribute in
“improving convenience and facilitating the access [to
healthcare]” (C_Ba_WS, male doctor). However, some PLWH
expressed worries that the platform “was intended to make
savings in healthcare and decrease the number of visiting hours
at the doctors’ [office]” (P_An_WSm).
Effects on Workload?
A discussion point among several clinicians was whether the
mHealth platform would increase or decrease their workload.
In this way, 1 clinician stated:
I’m interested in how this [the mHealth platform]
would work around our end and to see how
much...drudgery can be taken out of the
work...‘cos...there's a lot of work processing records.
[C_Br_WS, male doctor]
Although some participants were convinced that the platform
could save time and clinicians “would have more resources for
other things” (C_Ba_WSm, female doctor), others argued that
it would require more work:
...for a clinician if you have to do that, you have to
go to the results, interpret the results and then loading
them onto the website or the app or the platform, and
then there’s also additional, yeah, workload.
[C_An_WS, male doctor]
Discussion
Implications and Comparison With Prior Work
Participation is considered a key principle for designing health
interventions and technologies in ways that are accessible and
meaningful to people in different life situations [23,29,30]. In
this section, we compare the outcomes of our co-design process
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 10 | e184 | p.10http://mhealth.jmir.org/2018/10/e184/
(page number not for citation purposes)
Marent et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
with the results of previous studies that involved PLWH in the
design of HIV apps and highlight how co-design findings can
inform mHealth developments. We detail this by illustrating
how the findings informed the development of the EmERGE
platform.
Target Group for HIV mHealth
The complexities of interpreting the meanings of viral load and
other numerical definitions of HIV health have been widely
discussed in relation to self-managing HIV [31,32]. Our results
reflect this literature by highlighting patients’ and clinicians’
concerns that having access to one’s health data requires the
ability to interpret and use these data. These capacities were not
anticipated to be equally distributed among population groups.
In the context of HIV care, we found that years since diagnosis
with HIV and the relative stability of the HIV condition can
configure the meaning of having access to blood test results and
other quantified health data [22]. In the case of newly diagnosed
and unstable HIV conditions, direct access to numbers was
associated with bringing anxiety and uncertainty into care
practices. In the study of Swendeman et al [18], clinicians
suggested several ways in which mHealth devices should
particularly address newly diagnosed patients and patients with
comorbidities. Our data support the view that medication
reminders, options to monitor blood results, etc, are particularly
useful for these patient populations. However, our analysis
suggests that when implementing mHealth with newly diagnosed
or unstable patients, the most recent test results should be
discussed within the context of a face-to-face clinical encounter
before being sent to a patient’s mobile devices.
Medical Functionalities
In current HIV medicine, there is a strong focus on viral
suppression as the ultimate goal of ART. Therefore, both the
collection of biomarkers by means of blood tests and the close
surveillance of patients’ adherence to the treatment regime play
a key role in monitoring HIV progression [33]. This is reflected
in our findings as well as those of other studies where the storing
and tracking of lab results and medication and appointment
reminders were identified as desirable app functionalities for
PLWH [14-18]. Access to blood test results has been imagined
and anticipated as being an important function by both patients
and clinicians. Clinicians in the study of Swendeman et al [18]
additionally pointed out that messages or feedback from health
care providers to patients could be used to enhance patient
motivation to treatment adherence. Although two-way
communication features have not yet been considered within
the development of comprehensive HIV mHealth platforms
based on interacting apps and Web interfaces [14-16], with
options to exchange messages between patients and clinics
currently being implemented through basic cell phone text
messaging (short message service) services [34], many of our
co-design participants did regard this as an important
functionality to maintain relationships and exchange information
and concerns with their care providers. However, although the
inclusion of two-way communication functions might be
considered as an important direction for the development of
mHealth, there remain significant challenges concerning how
to achieve this in practice. In the case of EmERGE, discussions
about how two-way communication between clinicians and
patients could be facilitated in a way that does not significantly
increase clinicians’ workloads are still ongoing, and this feature
is not yet realized within the new care platform.
Social Functionalities
PLWH imagined several social functionalities that would
support them in managing their HIV condition. Continued
exchange among peers is important for individuals to feel less
alone while engaging in chronic illness self-management and
to generate knowledge that is based on personal experiences
[35]. However, frequent interaction with peers may often not
be feasible because of spatiotemporal limitations or fears of
stigmatization in face-to-face environments. Along with other
studies, our findings underscore perceptions of potential users
that mHealth could facilitate a comfortable and safe environment
for PLWH to engage in peer support [14-17,36]. In addition,
our participants imagined an app supporting them while traveling
internationally (eg, managing HIV intake across time zones) or
help to make the general public more knowledgeable about HIV.
At the time of writing, this has not been included in the first
iteration of the platform but remains an option for later
developments.
General Features
Our findings have highlighted that both patients and clinicians
anticipated it as essential that an mHealth platform for HIV care
should be based on the highest standards of security measures.
Concerns about security and privacy implications of mHealth
for HIV have also been stressed by previous studies [14-16].
However, our study (as well as one other [18]) has also revealed
clinicians’ perspectives that novel mHealth platforms could
provide higher standards of security as compared with older
technologies such as email communication. Many other general
features (such as credibility, news feeds, simplicity, cost, and
customizability) have been identified as important through our
research as well as previous studies [15,17] and should be
considered in mHealth developments. Working in a multilingual
European context, we found that it was of great importance that
mHealth apps are available in the local language. In the case of
EmERGE, the app will offer the option to choose between the
5 main languages spoken in our study sites.
Implications for Further Research
In the field of digital health studies, it has been stressed that
many of the social and ethical consequences of mHealth remain
under-researched [37]. Through the first stage of a co-design
process, developed and implemented as a central component of
the EmERGE project, participants had the opportunity to express
their concerns and anxieties about mHealth, and our analysis
of the results of this process has enabled us to help fill this gap
in the literature. This paper has illustrated how working closely
with clinicians and PLWH in a process of co-design can
contribute to a fuller understanding not only of the perceived
benefits associated with mHealth but also of the potential
unintended or negative consequences that users envisage and
how these insights can be reflected in mHealth platform design.
However, this is just the first stage of the co-design work in
EmERGE. Our approach to co-design is set within a broad
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sociotechnical understanding of digital health developments
that recognizes design as a continuous and co-constituting
process that begins before the technology itself is present and
continues well into implementation and use phases. Once in
use, platforms, apps, and websites are in a continuous process
of transformation [38]. They require constant fixes, updates,
and versions, not only because of technological changes but
also because of necessary sociocultural developments that
accompany them. Co-design thus requires ongoing engagement
with actual practices where technology has to be tamed and
tinkered with to fit specific situations of usage [39]. Engaging
with practices of design and use provide valuable insights into
how people approach, imagine, anticipate, and ultimately interact
with technologies, and this can contribute toward an
understanding of the situations and conditions within which
mHealth can facilitate or undermine practices of care [22,40].
We propose that co-design approaches that are continuous
throughout the lifecycle of mHealth interventions are likely to
provide timely and relevant insights toward the creation of
meaningful and effective mHealth solutions. As the EmERGE
mHealth platform is fully integrated into the local care pathways,
we will continue this co-design work with clinicians and PLWH
as we seek to investigate and to improve the technology in-use
in specific contexts.
Limitations
Although we aimed to recruit a broad variety of co-design
participants, among PLWH, white gay men were
over-represented compared with women and migrant groups.
Among clinicians, female doctors were over-represented in
comparison with male participants and clinicians from other
medical backgrounds (nurses, psychologists, etc). We also have
to assume that participants that were more likely to be interested
in the use of mobile technology agreed to participate in this
study. These recruiting issues restrict the potentialities to
generalize the outcomes of this study. Another constraint might
be intrinsic to technology development projects. The limited
time frame between data collection and the start of the
development of the mHealth platform meant that the actual
coding of the data could only be performed by 1 researcher.
However, to enhance the rigor of the data analysis, initial codes
and categories were discussed and negotiated between the
research team on a bimonthly basis. Confirmation of reliability
was also provided through feedback from community partners
and the whole project consortium gathered at various meetings.
Although findings presented in this paper have highlighted
patients’ and clinicians’ perspectives toward desirable, or
hypothetical, functionalities for HIV mHealth apps, the next
phases of our project will enable us to evaluate the actual impact
of these functionalities on health experiences and practices.
Conclusions
In this study, participatory co-design methods have been used
to (1) elicit experiences of living with HIV and of working in
HIV care, (2) identify functionalities and features for an mHealth
platform that PLWH and clinicians regard as useful for HIV
treatment and care, and (3) identify potential benefits as well
as risks and concerns of such a platform. Through our analysis,
we have highlighted how this process allowed us to better
understand how clinicians and patients were approaching,
imagining, and anticipating what it is that the platform could
do for HIV care. Our approach to co-design enabled us to
facilitate early engagement in the mHealth platform, enabling
patient and clinician feedback to become embedded in the
development process at a preprototype phase. Although the
technologies in question were not yet present, understanding
how users approach, imagine, and anticipate technology formed
an important source of knowledge and proved highly significant
within the technology design and development process. At the
time of writing, the platform has been implemented and is being
more fully evaluated in 5 clinical sites in the context of the wider
EmERGE study. Co-design work will continue as users’
experiences of the new mHealth-based care pathway are
captured and shared both within and between sites to inform
further developments of the EmERGE HIV platform. Future
papers will explore these later phases of co-design and draw
out the implications of our approach and findings for mHealth
developments in HIV care.
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